The “maverick” disrupter has doubled the maximum deposit on which it will pay its highest interest rate, and imposes no ...

Telstra shares are up 22% so far in 2025, and Macquarie remains positive on the company. It reaffirms its "Outperform" rating ...

In the pharma sector, Sandeep Bhatia, Managing Director and Head of Equity – India at Macquarie Capital flagged uncertainties ...

Macquarie Bank's popular savings account will now pay an ongoing interest rate of 4.50% p.a. on balances up to $2 million, ...

This week, we're excited to bring you more great moments from the past 12 years, straight from the SCG vaults\! Get ready for ...

Flight Centre shares have had a bumpy ride in 2025, but Macquarie sees clear skies ahead. The post Macquarie predicts 25% ...

Macquarie said the L90 launch shifts the narrative for NIO following the underwhelming rollout of the L60, and could support a re-rating of the stock, which has long traded at a discount to peers on ...

More last-minute modifications to tariff rates and a disappointing July jobs report weighed heavily on investors on Friday.

The Dow Jones Industrial Average dropped 542.40 points, or 1.23%, closing at 43,588.58. The S&P 500 shed 1.60% to end at ...

The Commonwealth Bank of Australia (ASX: CBA) share price was under pressure in July. Let's see why investors were hitting ...

A rebound on Wall Street and in the dollar has not allayed investor concerns about the ability of U.S. assets to outperform ...

Only two out of the 20 constituents on the Nifty Pharma index are trading with gains. Sun Pharma is the top loser on the ...